Differential Gene Expression Patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction

Overview

Journal Sci Rep

Specialty Science

Date 2024 Feb 10

PMID 38341440

Authors

Mohammad Elahimanesh

Nafiseh Shokri

Elmira Mahdinia

Payam Mohammadi

Najmeh Parvaz

Mohammad Najafi

Affiliations

Soon will be listed here.

Abstract

The ST-elevation Myocardial Infarction (STEMI) and Non-ST-elevation Myocardial Infarction (NSTEMI) might occur because of coronary artery stenosis. The gene biomarkers apply to the clinical diagnosis and therapeutic decisions in Myocardial Infarction. The aim of this study was to introduce, enrich and estimate timely the blood gene profiles based on the high-throughput data for the molecular distinction of STEMI and NSTEMI. The text mining data (50 genes) annotated with DisGeNET data (144 genes) were merged with the GEO gene expression data (5 datasets) using R software. Then, the STEMI and NSTEMI networks were primarily created using the STRING server, and improved using the Cytoscape software. The high-score genes were enriched using the KEGG signaling pathways and Gene Ontology (GO). Furthermore, the genes were categorized to determine the NSTEMI and STEMI gene profiles. The time cut-off points were identified statistically by monitoring the gene profiles up to 30 days after Myocardial Infarction (MI). The gene heatmaps were clearly created for the STEMI (high-fold genes 69, low-fold genes 45) and NSTEMI (high-fold genes 68, low-fold genes 36). The STEMI and NSTEMI networks suggested the high-score gene profiles. Furthermore, the gene enrichment suggested the different biological conditions for STEMI and NSTEMI. The time cut-off points for the NSTEMI (4 genes) and STEMI (13 genes) gene profiles were established up to three days after Myocardial Infarction. The study showed the different pathophysiologic conditions for STEMI and NSTEMI. Furthermore, the high-score gene profiles are suggested to measure up to 3 days after MI to distinguish the STEMI and NSTEMI.

References

Salari N, Morddarvanjoghi F, Abdolmaleki A, Rasoulpoor S, Khaleghi A, Afshar Hezarkhani L . The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023; 23(1):206. PMC: 10122825. DOI: 10.1186/s12872-023-03231-w. View

El-Beshbishy H, Maria R, Bardi F . Biochemical and C-reactive protein alterations in myocardial infarction periodontitis patients. Am J Med Sci. 2014; 348(3):181-5. DOI: 10.1097/MAJ.0000000000000253. View

Vausort M, Wagner D, Devaux Y . Long noncoding RNAs in patients with acute myocardial infarction. Circ Res. 2014; 115(7):668-77. DOI: 10.1161/CIRCRESAHA.115.303836. View

Tan B, Liu M, Yang Y, Liu L, Meng F . Low expression of PIK3C2A gene: A potential biomarker to predict the risk of acute myocardial infarction. Medicine (Baltimore). 2019; 98(14):e15061. PMC: 6456027. DOI: 10.1097/MD.0000000000015061. View

Stanojevic D, Apostolovic S, Stokanovic D, Momcilovic S, Jevtovic-Stoimenov T, Salinger-Martinovic S . Galectin-3 in Acute Myocardial Infarction Patients with Atrial Fibrillation. Med Princ Pract. 2019; 28(3):284-290. PMC: 6597920. DOI: 10.1159/000497611. View

Vaccarino L, Vitale S, Caruso M, Palmeri M, Scola L, Bova M . Myocardial infarction marker levels are influenced by prothrombin and tumor necrosis factor-α gene polymorphisms in young patients. Cytokine. 2012; 61(1):218-22. DOI: 10.1016/j.cyto.2012.09.021. View

Varbo A, Freiberg J, Nordestgaard B . Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population. Clin Chem. 2015; 61(3):533-43. DOI: 10.1373/clinchem.2014.234146. View

Sabatasso S, Moretti M, Mangin P, Fracasso T . Early markers of myocardial ischemia: from the experimental model to forensic pathology cases of sudden cardiac death. Int J Legal Med. 2017; 132(1):197-203. DOI: 10.1007/s00414-017-1605-7. View

Sahinarslan A, Kocaman S, Bas D, Akyel A, Ercin U, Zengin O . Plasma neutrophil gelatinase-associated lipocalin levels in acute myocardial infarction and stable coronary artery disease. Coron Artery Dis. 2011; 22(5):333-8. DOI: 10.1097/MCA.0b013e3283472a71. View

10.

Soares A, Carvalho L, Bonilha I, Virginio V, Nadruz Junior W, Coelho-Filho O . Adverse interaction between HDL and the mass of myocardial infarction. Atherosclerosis. 2018; 281:9-16. DOI: 10.1016/j.atherosclerosis.2018.12.002. View

11.

Anvari M, Karimi M, Shafiee A, Boroumand M, Bozorgi A, Sedaghat R . Complementary Diagnostic Value of Heart Type Fatty Acid-binding Protein in Early Detection of Acute Myocardial Infarction. Crit Pathw Cardiol. 2018; 17(1):43-46. DOI: 10.1097/HPC.0000000000000107. View

12.

Reiter R, Henry T, Traverse J . Preinfarction angina reduces infarct size in ST-elevation myocardial infarction treated with percutaneous coronary intervention. Circ Cardiovasc Interv. 2013; 6(1):52-8. PMC: 3607669. DOI: 10.1161/CIRCINTERVENTIONS.112.973164. View

13.

Cakar M, Gunduz H, Varim C, Ozdemir F, Vatan M, Akdemir R . Correlation between D-dimer levels and coronary artery reperfusion in acute myocardial infarction patients after thrombolytic treatment. Blood Coagul Fibrinolysis. 2013; 24(6):608-12. DOI: 10.1097/MBC.0b013e328360a53f. View

14.

Pan T, Jiang C, Zhang H, Han X, Zhang H, Jiang X . The low-dose colchicine in patients after non-CABG cardiac surgery: a randomized controlled trial. Crit Care. 2023; 27(1):49. PMC: 9903414. DOI: 10.1186/s13054-023-04341-9. View

15.

Li L, Li S, Wu M, Chi C, Hu D, Cui Y . Early diagnostic value of circulating microRNAs in patients with suspected acute myocardial infarction. J Cell Physiol. 2019; 234(8):13649-13658. DOI: 10.1002/jcp.28045. View

16.

Fuernau G, Zaehringer S, Eitel I, de Waha S, Droppa M, Desch S . Osteoprotegerin in ST-elevation myocardial infarction: prognostic impact and association with markers of myocardial damage by magnetic resonance imaging. Int J Cardiol. 2012; 167(5):2134-9. DOI: 10.1016/j.ijcard.2012.05.101. View

17.

Park H, Noh J, Eun J, Koh Y, Seo S, Park W . Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction. Oncotarget. 2015; 6(15):12970-83. PMC: 4536992. DOI: 10.18632/oncotarget.4001. View

18.

Aa N, Lu Y, Yu M, Tang H, Lu Z, Sun R . Plasma Metabolites Alert Patients With Chest Pain to Occurrence of Myocardial Infarction. Front Cardiovasc Med. 2021; 8:652746. PMC: 8103546. DOI: 10.3389/fcvm.2021.652746. View

19.

Dejanovic V, Bogavac-Stanojevic N, Kotur Stevuljevic J, Vukasinovic A, Stefanovic A, Kafedzic S . Circulating levels of inflammatory parameters pentraxin-3, cyclophilin and heparin-binding epidermal growth factor-like growth factor in patients with ST-elevation myocardial infarction. Scand J Clin Lab Invest. 2019; 80(1):66-72. DOI: 10.1080/00365513.2019.1698058. View

20.

Choi S, Jang H, Suh Y, Park S, Oh P, Moon J . Clinical Implication of Hypoxic Liver Injury for Predicting Hypoxic Hepatitis and In-Hospital Mortality in ST Elevation Myocardial Infarction Patients. Yonsei Med J. 2021; 62(10):877-884. PMC: 8470566. DOI: 10.3349/ymj.2021.62.10.877. View